Search results
Results from the WOW.Com Content Network
Amgen, headquartered in California, is a publicly traded company and one of 30 in the Dow Jones Industrial, according to a state news release. It has more than 27,000 employees globally.
Encouraging comments from Amgen about the 52-week Phase 2 trial helped fuel an 8% rise in the company's shares over the past year. That rally lost steam in recent weeks as investors sought details ...
The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung ...
(Reuters) -Amgen will test its obesity drug candidate in patients at risk of weight-related conditions such as heart, liver and kidney diseases in its late-stage trial, the company's CEO Robert ...
Amgen expects to have results from a 52-week, mid-stage trial of MariTide late this year. Some of those patients will be enrolled in another study for a second full year of dosing.
Weight-loss drugmaker Eli Lilly's shares fell 1.6% while Novo Nordisk's Denmark-traded shares dropped 3.9%, on track for their biggest one-day fall since November 2022. Amgen is conducting mid ...
GLP-1, which releases insulin from the pancreas and promotes feelings of fullness, was first studied for diabetes, leading to Novo Nordisk's successful GLP-1 drug Ozempic, which under the brand ...
Amgen's positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its stock up more than 13% in trading Friday.CEO Bob Bradway shared a peek at phase II results of the ...